Pharmaceuticals company Wockhardt announced Q1FY24 results: Revenue of Rs 658 crore in Q1FY24 compared to Rs 596 crore in Q1FY23 registering a growth of 10%. EBITDA for Q1FY24 is Rs 32 crore as compared to Rs (15) crore in Q4FY23 registering a 3-fold growth. 11 patents were filed during Q1FY24 and the cumulative filings to date are 3,250. The company was granted 12 patents during Q1FY24 and now holds 822 patents. R&D; expenses remained constant at Rs 36 crore in Q1FY24 compared to Q1FY23. Profit After Tax of Rs (136) crore in Q1FY24 compared to Rs (75) crore in Q1FY23. Result PDF